Dr. Nowarat Songsiridej, MD

Dr. Songsiridej practices at Sanford Medical Center - Bismarck in Bismarck, North Dakota.

Dr. Songsiridej's NPI, 1346321429, was assigned on October 17, 2006. Dr. Songsiridej holds North Dakota license 5975.

Dr. Songsiridej's primary practice is Sanford Medical Center - Bismarck, at 300 N 7th St, Bismarck, ND 58501 in Burleigh County. The practice phone is (701) 323-6000.

Dr. Songsiridej's primary practice is Sanford Medical Center - Bismarck in Bismarck, North Dakota. Dr. Songsiridej is also affiliated with Sanford Bismarck Medical Center. The medical group on file is Sanford Bismarck Medical Center. Dmand AI also links Dr. Songsiridej to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Songsiridej practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Songsiridej's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Songsiridej is licensed in North Dakota.

CMS data shows 396 Medicare services from Dr. Songsiridej across 3 procedure codes in 2024, for 165 Medicare patients. Medicare paid $23,866 for them. Every service was in an office.

CMS counts 165 Medicare patients who saw Dr. Songsiridej in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have arthritis, and 73% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Songsiridej's median patient age at 74, with 69% women.

In 2024, Dr. Songsiridej wrote 1,549 Medicare Part D claims for 205 patients. 93% of them were for generic drugs. CMS names the drug for 1,355 of them, across 20 drugs with 11 or more claims each, at $111,868 in total drug cost. In 2023, CMS named 730 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Songsiridej for performance year 2024, reported as part of a group. Dr. Songsiridej accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Songsiridej as offering telehealth.

CMS Open Payments shows 114 general payments to Dr. Songsiridej from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Celgene Corporation paid the most, $448.